MaRS Innovation specializes in extreme early-stage seed investing for companies and technology emerging from our 15 members.
New York, NY and Toronto Canada, Dec. 21, 2017 (GLOBE NEWSWIRE) — Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, and MaRS Innovation, a non-profit organization supporting the …
Click on link to read an article by Drs. Rafi Hofstein and Werner Lanthaler published in December 2017 in the online publication Global University Venturing: http://bit.ly/2Ba9vH2
Toronto, Nov. 28, 2017 (GLOBE NEWSWIRE) — Fibrocor Therapeutics (Fibrocor) announced today that Mark Steedman has been appointed as its first president and CEO, and will serve as a member of Fibrocor’s board of directors.